By Associate Professor Michael Falster

Preprints

Cox E; Gale J; Van Gool K; Falster MO; Parr E; Ng A; Meyerowitz-Katz G; Colagiuri S; Nassar N; Gibson AA, 2026, Allied health service use for diabetes management: 10-year trends in Medicare service utilisation and out-of-pocket costs in New South Wales, Australia, http://dx.doi.org/10.2139/ssrn.7050523

Pairman L; Falster M; Fletcher V; Fink J; Chin P; Doogue M, 2026, Use of antiplatelet and anticoagulant medicines in patients following thromboembolic stroke, http://dx.doi.org/10.22541/au.177277517.77030612/v1

Quiroz JC; Brieger D; Jorm L; Sy RW; Falster MO; Gallego B, 2021, An observational study of clinical and health system factors associated with catheter ablation and early ablation treatment for atrial fibrillation in Australia, http://dx.doi.org/10.1101/2021.09.03.21263104

Trivedi R; Chapman N; Falster MO; Moran AE; Schutte AE; Zhou B; Picone DS, Hypertension detection, treatment and control in young adults in Australia, http://dx.doi.org/10.64898/2026.01.27.26345008

Falster MO; de Oliveira Costa J; Milder T; Carson J; Shadbolt C; Neuen BL; Arnott C; Wilson A; Jun M; Pratt N; Pearson S-A, The GLP-1 RA boom: Trends in publicly subsidised and private access in Australia, 2020-2025, http://dx.doi.org/10.1101/2025.10.30.25339120

Zoega H; Falster MO; Gillies MB; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer AL; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic CM; Pearson S-A, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520

Back to profile page